DiNuzzo Private Wealth’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
DiNuzzo Private Wealth's RNAM Position: Q1 2026 in Review
DiNuzzo Private Wealth sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $73 sold.
DiNuzzo Private Wealth first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $73 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- DiNuzzo Private Wealth reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- DiNuzzo Private Wealth sold 1 Avidity Biosciences share in Q1 2026, an estimated $73.
- DiNuzzo Private Wealth first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- DiNuzzo Private Wealth's Avidity Biosciences position peaked at $73 in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on DiNuzzo Private Wealth's 13F filing for Q1 2026, filed 8 Apr 2026.